The functional potential of the T-cell anti-cancer response was then assessed according to the production of IFN-γ, TNF-α, perforin, and Granzyme B. Our findings indicated that PD-L1 blockade by pentamidine enhanced the cytotoxic potential of T cells in all tested cancer cell lines. The gene discussed is PRF1; the disease is cancer.